Frances McSherry

3.2k total citations · 1 hit paper
63 papers, 2.2k citations indexed

About

Frances McSherry is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Frances McSherry has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 19 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Frances McSherry's work include Glioma Diagnosis and Treatment (26 papers), Brain Metastases and Treatment (12 papers) and Virus-based gene therapy research (8 papers). Frances McSherry is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Brain Metastases and Treatment (12 papers) and Virus-based gene therapy research (8 papers). Frances McSherry collaborates with scholars based in United States, Canada and Australia. Frances McSherry's co-authors include James E. Herndon, Katherine B. Peters, Annick Desjardins, Henry S. Friedman, William O. Williford, Salim Yusuf, John H. Sampson, Roger E. McLendon, Dina Randazzo and Gordana Vlahovic and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Frances McSherry

59 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent Glioblastoma Treated with Recombinant Poliovirus

2018 582 citations Annick Desjardins, James E. Herndon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frances McSherry United States	23	710	659	594	352	330	63	2.2k
April Coan United States	26	977 1.4×	1.3k 1.9×	655 1.1×	434 1.2×	281 0.9×	38	3.0k
Edward Pequignot United States	20	333 0.5×	1.3k 1.9×	459 0.8×	396 1.1×	75 0.2×	49	2.5k
Peter D. Cole United States	29	301 0.4×	567 0.9×	570 1.0×	408 1.2×	141 0.4×	135	2.6k
Markus Metzler Germany	31	428 0.6×	283 0.4×	543 0.9×	718 2.0×	80 0.2×	130	2.8k
Marshall Pitz Canada	23	330 0.5×	697 1.1×	585 1.0×	526 1.5×	341 1.0×	66	2.0k
Meredith Allen United Kingdom	11	705 1.0×	923 1.4×	226 0.4×	815 2.3×	122 0.4×	19	2.2k
M Wolf Australia	18	267 0.4×	683 1.0×	205 0.3×	137 0.4×	334 1.0×	51	1.8k
John F. Kuttesch United States	29	762 1.1×	628 1.0×	751 1.3×	620 1.8×	64 0.2×	64	2.4k
Florian Geßler Germany	26	605 0.9×	221 0.3×	238 0.4×	728 2.1×	52 0.2×	129	2.1k
Salvatore Maria Corsello Italy	31	148 0.2×	869 1.3×	334 0.6×	314 0.9×	91 0.3×	122	3.4k

Countries citing papers authored by Frances McSherry

Since Specialization

Citations

This map shows the geographic impact of Frances McSherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances McSherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances McSherry more than expected).

Fields of papers citing papers by Frances McSherry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances McSherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances McSherry. The network helps show where Frances McSherry may publish in the future.

Co-authorship network of co-authors of Frances McSherry

This figure shows the co-authorship network connecting the top 25 collaborators of Frances McSherry. A scholar is included among the top collaborators of Frances McSherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances McSherry. Frances McSherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Randazzo, Dina, Frances McSherry, James E. Herndon, et al.. (2021). Spiritual well-being and its association with health-related quality of life in primary brain tumor patients. Neuro-Oncology Practice. 8(3). 299–309. 15 indexed citations

Koontz, Bridget F., Erica Levine, Frances McSherry, et al.. (2021). Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP). Supportive Care in Cancer. 29(12). 7339–7349. 7 indexed citations

McSherry, Frances, et al.. (2019). Second primary cancers in long-term survivors of glioblastoma. Neuro-Oncology Practice. 6(5). 386–391. 5 indexed citations

Desjardins, Annick, James E. Herndon, Frances McSherry, et al.. (2019). Single‐institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice. Health Science Reports. 2(4). e114–e114. 11 indexed citations

Randazzo, Dina, Frances McSherry, James E. Herndon, et al.. (2019). Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population. Complementary Therapies in Clinical Practice. 36. 43–48. 8 indexed citations

Yi, John S., Neal Ready, Patrick Healy, et al.. (2017). Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab. Clinical Cancer Research. 23(24). 7474–7482. 62 indexed citations

Farber, S. Harrison, Sarah Sammons, Frances McSherry, et al.. (2017). Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis. Neuro-Oncology. 19(10). 1391–1397. 29 indexed citations

Peters, Katherine B., Eric Lipp, Elizabeth Miller, et al.. (2017). Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas. Journal of Neuro-Oncology. 137(2). 349–356. 44 indexed citations

Limon, Dror, Frances McSherry, James E. Herndon, et al.. (2017). Single fraction stereotactic radiosurgery for multiple brain metastases. Advances in Radiation Oncology. 2(4). 555–563. 44 indexed citations

10.

Affronti, Mary Lou, Katherine B. Peters, James E. Herndon, et al.. (2016). A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab. Therapeutics and Clinical Risk Management. Volume 13. 33–40. 5 indexed citations

11.

Affronti, Mary Lou, Karen Allen, John P. Kirkpatrick, et al.. (2016). Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ). Supportive Care in Cancer. 24(10). 4365–4375. 8 indexed citations

12.

Peters, Katherine B., Gordana Vlahovic, Lloyd M. Alderson, et al.. (2013). Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT.. Journal of Clinical Oncology. 31(15_suppl). e13015–e13015. 1 indexed citations

13.

Reardon, David A., James J. Vredenburgh, Annick Desjardins, et al.. (2012). Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma. Journal of Neuro-Oncology. 108(3). 499–506. 28 indexed citations

14.

Anderson, A., Shou-Hua Li, Kousick Biswas, et al.. (2011). Modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence. 120(1-3). 135–141. 82 indexed citations

15.

Kahn, Roberta, Kousick Biswas, Steven Shoptaw, et al.. (2009). Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug and Alcohol Dependence. 103(1-2). 59–64. 56 indexed citations

16.

Yu, Elmer, Karen Miotto, Evaristo Akerele, et al.. (2008). A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal☆. Drug and Alcohol Dependence. 97(1-2). 158–168. 47 indexed citations

17.

Mathew, James, Janet Wittes, Frances McSherry, et al.. (2005). Racial differences in outcome and treatment effect in congestive heart failure. American Heart Journal. 150(5). 968–976. 27 indexed citations

18.

Lader, Ellis, Debra Egan, Sally Hunsberger, et al.. (2003). The effect of digoxin on the quality of life in patients with heart failure. Journal of Cardiac Failure. 9(1). 4–12. 33 indexed citations

19.

Kibbe, Melina R., Frances McSherry, Franklin A. Bontempo, et al.. (2002). Can screening for genetic markers improve peripheral artery bypass patency?. Journal of Vascular Surgery. 36(6). 1198–1206. 16 indexed citations

20.

Rich, Michael W., Frances McSherry, William O. Williford, & Salim Yusuf. (2001). Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. Journal of the American College of Cardiology. 38(3). 806–813. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact